Frontier Medicines is a pre-clinical stage biopharmaceutical company. Founded by Chris Varma in 2018, Frontier Medicines is backed by investors that include Data Collective DCVC, Deerfield, DROIA, MPM Capital, and RA Capital Management and is headquartered in San Francisco.